24 A subset of intracellular mono-ADP-ribosyltransferases diphtheria toxin-like (ARTDs, aka 25 mono-PARPs) is induced by type I interferons. Some of these mono-ARTDs feature antiviral 26 activity while certain RNA viruses, including Chikungunya virus (CHIKV), encode mono-ADP-27 ribosylhydrolases, suggesting a role for mono-ADP-ribosylation (MARylation) in host-virus 28 conflicts. CHIKV expresses four non-structural proteins (nsP1-nsP4), with nsP3 containing a 29 macrodomain that hydrolyzes and thereby reverses protein MARylation in vitro and in cells. 30 This de-MARylation activity is essential as hydrolase inactivating mutations result in 31 replication defective virus. However, the substrates of MARylation during CHIKV infection 32 are unknown and thus it is unclear how the macrodomain contributes to virus replication 33 and how mono-ARTD-dependent MARylation confers antiviral immunity. We identified 34 ARTD10 and ARTD12 as restriction factors for CHIKV replication in a catalytic activity-35 dependent manner. CHIKV replication requires processing of the non-structural polyprotein 36 nsP1-4 by the nsP2-encoded protease and the assembly of the four individual nsPs into a 37 functional replication complex. Expression of ARTD10 and ARTD12 resulted in a reduction 38 of processed nsPs. Similarly, MAR hydrolase inactive CHIKV replicon mutants revealed a 39 decrease in processed nsPs, comparable to an nsP2 protease defective mutant. This 40 suggested that the macrodomain contributes to nsP2 protease activity. In support, a 41 hydrolase-deficient virus was complemented by a protease-deficient virus. We 42 hypothesized that MARylation regulates the proteolytic function of nsP2. Indeed, we found 43 that nsP2 is MARylated by ARTD10. This inhibited nsP2 protease activity, thereby preventing 44 polyprotein processing and consequently virus replication. This inhibition was antagonized 45 by the MAR hydrolase activity of nsP3. Together, our findings provide a mechanistic 46 explanation for the need of the viral MAR hydrolase for efficient replication of CHIKV. 47 Author Summary 48 Infectious diseases still pose major health threats. Especially fast evolving viruses find ever 49 new strategies to manipulate the immune response. With climate warming and increased 50 human mobility vector-borne pathogens like Chikungunya virus (CHIKV) spread and cause 51 world-wide epidemics. Beyond the acute phase, CHIKV patients regularly suffer from chronic 52 rheumatism. This entails a decline in life quality and an economic burden. To date no drugs 53 are approved and the mode of pathogenesis remains elusive. Here we describe a mechanistic 54 function of the CHIKV nsP3 macrodomain. We found that the viral nsP2 is mono-ADP-55 ribosylated interfering with its auto-proteolytic function. The nsP3 macrodomain removes this 56 modification and restores the protease activity that is essential for replication. Because 57 macrodomains are highly conserved they might represent broad antiviral targets. 58 59 Introduction 60 Upon viral infection host cells initiate an antiviral immune response. Because the regulation 61 of protein function through post-translational modifications (PTMs) is among the quickest 62 mechanisms to adapt to challenges such as viral infections, PTMs display an essential part of 63 antiviral signaling. Viruses have developed multifaceted strategies to evade or even hijack 64 cellular mechanisms, e.g. encoding proteins that regulate PTMs and thereby counteract the 65 antiviral reaction of the host [1-5]. Recent findings have elaborated on the role of intracellular 66 ADP-ribosylation at the host-pathogen interface [6-12]. ADP-ribosylation is an ancient PTM of 67 proteins and intracellularly mainly catalyzed by members of the ADP-ribosyltransferase 68 diphtheria toxin-like (ARTD) family (also known as poly-ADP-ribosylpolymerases (PARPs)), 69
.
Results

141
ARTD10 and ARTD12 are restrictive for CHIKV replication 142 CHIKV relies on a functional macrodomain for replication [45] . This suggests that the capability 143 to reverse MARylation is essential for proper virus replication and that mono-ARTDs function 144 as antiviral host factors. To identify mono-ARTDs that potentially affect CHIKV replication we 145 performed knockdown experiments (Fig. 1a ). HEK293 cells were transfected with siRNA oligo 146 pools targeting IFNa-inducible mono-ARTDs ( Supplementary Fig. 1a and [6] ), such as ARTD10, 147 ARTD12, ARTD8, or ARTD7, prior to transfection with CHIKV replicon RNA. This replicon 148 encodes the four non-structural proteins but lacks the open reading frame of the structural 149 proteins. Instead, the subgenomic promotor of the replicon controls the expression of Gaussia 150 luciferase, which we analyzed as surrogate for virus replication (Fig. 1b) [46] . Replication was 151 analyzed at 9, 24 and 30 hours post transfection (hpt) (Fig. 1a) . At the early time point ARTD10 152 and ARTD12 knockdowns showed a significant increase in replication, while the effect 153 decreased at later time points. Knockdowns of ARTD8 or ARTD7 only allowed for minor 154 increases in replication compared to control (Fig. 1a ). Based on these findings we decided to 155 focus on ARTD10 and ARTD12 and their role in CHIKV replication. We employed HEK293 cells 156 stably expressing TAP-tagged ARTD10 or ARTD12, either wildtype (wt) or catalytically inactive 157 mutants ( Supplementary Fig 1b,c and [14] ), to test whether overexpression of these proteins 158 interferes with CHIKV replication (Fig. 1c-g) . Protein expression was induced by doxycycline 159 (Dox) treatment prior to transfection with replicon RNA. Doxycycline treatment itself had little 160 effect on CHIKV replication ( Supplementary Fig. 1d ), still control cells were always treated with 161 doxycycline as well. ARTD10 and ARTD12 reduced replication two-fold, while the respective 162 catalytically inactive variants, ARTD10-G888W(GW) or ARTD12-H564Y(HY), showed little 163 effect ( Fig. 1c,d ), suggesting that the MARylation activity of these enzymes is required to 164 interfere with CHIKV replication. These differences are not attributed to variations in protein 165 levels, as the mutants were expressed more efficiently compared to the wt proteins ( Fig. 1e , 166 Supplementary Fig. 1c ). Similarly, HEK293 cells transiently expressing ARTD10 or ARTD12 167 showed reduced replicon replication, whereas no influence of the PARylating ARTD1 or 168 ARTD14 enzymes, which do not respond to IFNa, was observed ( Supplementary Fig. 1e,f) . 169
Further analysis revealed that ARTD10 and ARTD12 had additive repressing effects on 170 replication when analyzed 30 hpt (Fig. 1f) . 171 172 To expand on these findings, we determined the effects of ARTD10 and ARTD12 on the 173 replication cycle of infectious CHIKV, which expresses EGFP from an additional subgenomic 174 promoter ( Fig. 1g) [47] . Overexpression of ARTD10 and ARTD12 resulted in a significant 175 decrease of EGFP expressing cells as measured by flow cytometry 24 and 48 hpi ( Fig. 1g and 176 Supplementary Fig. 2 ). In this set-up, the catalytically inactive mutant of ARTD12 restricted 177 replication to the same extend as the wt protein, indicating that ARTD12 may have more than 178 one mode of action. In contrast, ARTD10-GW enhanced viral replication, hinting at a dominant 179 negative effect and thereby demonstrating dependency on catalytic activity of ARTD10 as a 180 CHIKV restriction factor. Of note is also that the inhibitory effects of ARTD10 and ARTD12 are 181 more pronounced at early time points (24 hpi) compared to later time points (48 hpi). Taken 182 together our findings indicate, that MARylation driven by the IFNa responsive ARTD10 and 183 ARTD12 restricted CHIKV replication. 184
185
MAR interferes with polyprotein processing 186
To gain insight into a possible mechanism of how MARylation by ARTD10 and ARTD12 might 187 interfere with viral replication, we determined the abundance of auto-proteolytically 188 processed nsP3. Therefore, we made use of EGFP-encoding variants of the replicon ( 2 EGFP 189 and 3 EGFP, in which EGFP is integrated after amino acids 466 or 383 in nsP2 or nsP3, 190 respectively Fig. 1b and [48] ), enabling us to visualize processed nsP2 or nsP3 proteins using a 191 GFP-specific antibody (Fig. 2) . HEK293 cells stably expressing ARTD10 or ARTD10-GW were 192 employed. These cells were then transfected with or without ARTD12 expressing constructs 193 and induced for ARTD10 expression prior to transfection with 3 EGFP replicon RNA. The 194 analysis of whole cell lysates showed a reduction in processed nsP3 in presence of either the 195 enzymatically active ARTD12 or ARTD10. NsP3 was further reduced when both enzymes were 196 expressed ( Fig. 2a ). These findings led us hypothesize that MARylation hampers polyprotein 197 processing. Proper polyprotein processing is a prerequisite for RNA replication [43], consistent 198 with impaired replication of a mutant replicon with an inactive protease (nsP2-C478A/S482A, 199 referred to as CASA) ( Fig. 2b,c) [44] . Similarly, a functionally active macrodomain is needed for 200 replication as substitution of key amino acids in the macrodomain (D10A, V33E, for details 201 concerning the replicon construct see Fig. 1b ) interfered with replication ( Fig. 2b,c) [6, 9] . To 202 analyze how the lack of a functional macrodomain compromised replication, we determined 203 the abundance of proteolytically processed nsP2 ( Fig. 2d , for the specificity of the antibody 204 see Supplementary Fig. 3a,b ). As expected, nsP2 was detectable after transfection of the 205 wildtype (wt) but not the CASA mutant replicon (Fig. 2d ). Similarly, nsP2 was not detectable, 206 when expressed from hydrolase deficient replicons ( Fig. 2d ), implying a defect in nsP2-207 mediated polyprotein processing in the absence of MAR hydrolase activity. This observation 208 was corroborated with the 3 EGFP and 2 EGFP replicons and mutants thereof ( Fig. 2e-g) . 209
Although replication of the EGFP-encoding variants was reduced compared to the wt replicon, 210 it remained dependent on functional protease and MAR hydrolase activities ( Fig. 2e,f) . As for 211 nsP2, GFP-tagged processed nsP3 was not properly generated from the hydrolase deficient 212 replicons ( Fig. 2g ). However, compared to the CASA mutant, at least in the longer exposure, 213 some signal for processed nsP3 was detectable, implicating that the loss of MAR hydrolase 214 activity did not completely abolish polyprotein processing as in case of the CASA mutant (Fig. 215 Then we examined whether replication could also be rescued by co-expression of plasmid-237 encoded nsP2 or nsP3 and the respective replicon mutant RNA (CASA or V33E) 238 ( Supplementary Fig. 4 ). Co-expression of the nsP2-459-798 protease domain partially rescued 239 replication of the CASA mutant suggesting that indeed polyprotein synthesis takes place 240 ( Supplementary Fig. 4a-c) . In contrast, co-expression of nsP3 or the isolated nsP3 241 macrodomain was not sufficient to rescue replication of a hydrolase deficient replicon mutant 242 ( Supplementary Fig. 4d -f). To overcome possible differences in the subcellular localization of 243 replication hubs and plasmid-expressed nsP3 macrodomain, we fused the macrodomain to an 244 anti-GFP-nanobody to enhance targeting to sites of replication of the EGFP encoding 245 replicons. We transfected HEK293 cells with plasmids coding for a GFP-nanobody-nsP3-246 macrodomain fusion protein prior to transfection with the 3 EGFP-replicon RNA. We analyzed 247 GFP by flow cytometry (Fig. 3i -k, Supplementary Fig. 5 ). Whereas the overall amount of GFP-248 positive cells when transfected with the V33E mutant was low compared to the wildtype and 249 stayed unaffected by co-expression of GFP-nanobody-nsP3-macrodomain ( Fig. 3i ), we 250 observed an increase in GFP intensity dependent on hydrolytic activity of the GFP-nanobody 251 fusion protein ( Fig. 3j ,k, Supplementary Fig. 5 ). In line with this replication in presence of the 252 wildtype GFP-nanobody-nsP3-macrodomain was slightly but significantly increased ( Fig. 3l ). 253
Further, the analysis of nsP3 revealed an increase in its processed form ( Fig. 3m ,n), indicating 254 that the co-expression of the GFP-nanobody-nsP3-macrodomain at least to some extend was 255 able to rescue the CHIKV replicon lacking hydrolase activity. 256 257 Taken together, these data suggest strongly that polyprotein synthesis of the different 258 mutated replicons occurs and further support the hypothesis that MARylation affects 259 polyprotein processing. 260
CHIKV nsP2 is a substrate for MARylation in vitro and in cells 261
Consequences of protein MARylation are poorly understood. Our previous studies indicated 262 that ARTD10-dependent MARylation impairs the catalytic activity of the kinase GSK3b, which 263 is antagonized by cellular MAR hydrolases [37, 49] . Furthermore, MARylation is reported to 264 affect protein-protein interactions, mRNA stability and translation [1] . Following our 265 hypothesis, we determined the consequences of MARylation on the protease activity of nsP2, 266 which is responsible for polyprotein processing [43] . Therefore, we tested whether nsP2 267 serves as substrate for mono-ARTDs. His6-tagged fusion proteins of CHIKV nsP2 or nsP2-459-268 798, comprising the protease domain, were incubated with His6-tagged catalytic domains of 269 ARTD7, ARTD8, ARTD10 and ARTD12 ( Fig. 4a , Supplementary Fig. 6 ). The corresponding genes 270 are IFNa responsive ( Supplementary Fig. 1a and [6] ). Moreover, we tested ARTD15, which is 271 not regulated by IFNa ( Supplementary Fig. 1a ). For all ARTD catalytic domains auto-ADP-272 ribosylation was measurable in presence of 32 P-NAD + even though the signal intensities varied 273 considerably between the different enzymes ( Fig. 4a , Supplementary Fig. 6a , b) [14, 16] . Both, 274 full length CHIKV nsP2 as well as the isolated protease domain were MARylated by the 275 catalytic domains of IFN-regulated ARTDs but not of ARTD15 (Figure 4a , Supplementary Fig.  276 6a). 277
278
The presence of nsP3 in ADP-ribosylation reactions using the catalytic domains of either 279 ARTD10 or ARTD12 reversed MARylation of nsP2 and the protease domain. Similarly, the 280 isolated macrodomain also efficiently de-MARylated nsP2 ( Fig. 4b, Supplementary Fig. 6b ). 281
We obtained similar results with nsP2 MARylated by full length ARTD10, while no MARylation 282 was obtained with ARTD10-GW ( Fig. 4c ). In addition, nsP2 was reversibly MARylated by full 283 length ARTD12 (Fig. 4d ). To complement these in vitro findings, we measured MARylation of 284 nsP2 expressed in HEK293 cells transfected with the 2 EGFP replicon (Fig. 4e ). The 285 immunoprecipitated nsP2-2 EGFP stained positively with a MAR binding reagent. In support, 286 this staining was reduced upon incubation with the recombinant nsP3 macrodomain, 287 providing evidence that this protein is MARylated in cells ( Fig. 4e) . Similarly, upon co-288 transfection of a plasmid expressing GFP-nsP2 and the V33E replicon, nsP2 stained positively 289 for MAR ( Fig. 4f ). Taken together, we identified CHIKV nsP2 as a new substrate for MARylation 290 in vitro and in cells in context of a viral infection. 291 292
MARylation of nsP2 reversibly inhibits its proteolytic activity 293
Having identified nsP2 as a new substrate for MARylation, we aimed at determining the 294 consequences of this modification on proteolytic activity. Therefore, we established a 295 protease assay using an nsP3/nsP4 junctional peptide (DELRLDRAGG|YIFSS) fused to GST and 296 EGFP ( Fig. 5a ) [50] [51] [52] . Accessibility between the two globular tags was achieved by including 297 a polylinker C-terminally of the cleavage site. This artificial substrate was cleaved by the 298 recombinant nsP2 protease with up to 90% processing observed after 120 min, but not by the 299 CASA proteolytically inactive mutant ( Fig. 5b ). Of note is that neither the C-terminal EGFP 300 fragment (fragment 1) nor the N-terminal GST fragment (fragment 2) were further cleaved, 301 supporting the specificity of the protease activity. Both, the substrate and the two nsP2 302 variants were stable when analyzed individually over 120 min (Fig. 5b) . 303
304
To assess the role of MARylation, the nsP2 protease domain was modified by ARTD10cat. This 305 prevented cleavage of the substrate, while ARTD10cat-GW had no effect ( Fig. 5c ). Successful 306
MARylation of nsP2-459-798 is indicated by its mobility shift on SDS-PAGE (Fig. 5c ). The 307 inhibition of the protease function by ARTD10cat was dose dependent (Fig. 5d ). To interrogate 308 whether de-MARylation was sufficient to reactivate protease activity, we co-incubated the 309 substrate with nsP2-459-798, ARTD10cat and nsP3 or nsP3-macro as indicated ( Fig. 5e ). MARylation, which was evident in the presence of hydrolase either by the reduced mobility 311 shift or by staining with the MAR reagent, reactivated protease activity (Fig. 5e ). The 312 processing efficiency was quantified by measuring the intensity of unprocessed substrate and 313 the two fragments by immunoblotting and densitometric analysis. This documented that 314
MARylation by ARTD10cat efficiently repressed nsP2-459-798 protease activity, which was 315 antagonized by nsP3 or the isolated macrodomain ( Fig. 5e,f) . Thus, these findings demonstrate 316 that the nsP2 protease domain is reversibly inhibited by MARylation and support our initial 317 hypothesis that MARylation inhibits polyprotein processing. We provide a mechanism how 318 MARylation antagonizes and consequently how the nsP3 macrodomain contributes to CHIKV 319 replication. 320 321 Discussion 322
Taken together, we established that ARTD10 and ARTD12 interfere with CHIKV RNA 323 replication and identified CHIKV nsP2 as target for MARylation by IFN-inducible mono-ARTDs. 324
Mechanistically, our results provide evidence for inhibition of the nsP2 protease function, 325 which is essential for viral replication, by ARTD10-dependent MARylation. This results in a 326 defect in CHIKV polyprotein processing and consequently in reduced replication. This 327
MARylation-dependent inhibition of the protease activity is antagonized by the macrodomain 328 of nsP3. Accordingly, the lack of MAR hydrolase activity prevents polyprotein processing. Thus, 329 our findings elucidate a mechanism for the importance of a functional macrodomain for CHIKV 330 replication. 331 332 ARTDs have been linked previously to restriction of virus replication [22] . In this context the 333 best studied ARTD family member is ARTD13 (ZAP, Zinc-finger antiviral protein), which is able 334 to bind viral RNA, promoting its decay or interfering with its translation [53] . Further, ARTD13, 335 which is catalytically inactive, contributes to the establishment of an antiviral immune 336 response by crosstalk with the miRNA pathway, thereby stimulating expression of antiviral 337 proteins, and by amplifying RIG-I signaling [53] . Antiviral activities have also been assigned to 338 ARTD10, ARTD12 and ARTD14. Overexpression of these ARTDs was shown to interfere with 339 Venezuelan equine encephalitis virus (VEEV) replication [7] . Additionally, ARTD12 was 340 described to restrict Sindbis Virus (SINV) and CHIKV replication amongst other RNA viruses [7] . 341
Further ARTD10, ARTD12 and ARTD14 downregulate cellular translation in cells infected with 342 VEEV, which in the case of ARTD12 depends on catalytic activity [8] . ARTD12 has also been 343 identified to restrict Zika virus (ZIKV) replication, which is mediated by depletion of the ZIKV 344 non-structural proteins NS1 and NS3 [26] . Dependent on its catalytic activity, ARTD12 seems 345 to promote poly-ADP-ribosylation (PARylation) of these two viral proteins. PAR chains in turn 346 are argued to serve as scaffold to recruit E3 Ubiquitin-ligases that modify NS1 and NS3 by K48-347 linked polyubiquitination and thereby enable their proteasomal degradation [26] . Indeed, this 348 concept has already been established for PARylation mediated by ARTD5 and 6 (tankyrase 1 349 and 2, respectively) [1]. More than 70 substrates have been identified to be regulated through 350 PAR-mediated poly-ubiquitination [54] . The proposed mechanism is that ARTD12, as it is 351 limited to MARylation, modifies NS1 and NS3, which serves as a seeding event for polymer 352 forming ARTDs, possibly ARTD5 or 6 [26] . However, the effect of MARylation on CHIKV 353 replication seems to be different as demonstrated by experiments with inhibitors of 354 proteasomal and lysosomal pathways in this study (Fig. 3a,b ). In addition to the ZIKV proteins, 355 the nucleocapsid protein of Coronavirus (CoV) was recently suggested to be ADP-ribosylated 356 during infection [55] . It will be interesting to identify the enzyme that catalyzes this 357 modification and moreover to define the molecular consequences, for example on capsid 358 formation. 359
360
In summary, these different reports suggest that ADP-ribosylation may interfere with multiple 361 viral functions. This is consistent with the observation that at least four of the 12 catalytically 362 active mono-ARTDs are induced by type I IFNs ( Supplementary Fig. 1a ) [1, 6, 11] . The fact that 363 the viral macrodomains display MAR hydrolase activity and thereby are able to reverse 364
MARylation of viral as well as cellular substrates [6, 9, 10, 39] 
Cloning and mutagenesis 450
The SP6-CHIKV-replicon-SG-GLuc (hereafter referred to as replicon wt) construct was obtained 451 from B. Kümmerer [46] . EGFP insertions were created on the basis of Utt et al 2016 [48] . 452 Linkers (5'-ACTAGTTCCGAGCTCGAG-3') with restriction sites for SpeI and XhoI were 453 introduced by PCR based mutagenesis using the Q5 mutagensis kit (NEB) after codon 466 of 454 nsP2 ( 2 EGFP) or after codon 383 of nsP3 ( 3 EGFP). The sequence encoding EGFP was amplified 455 from pEGFP-C1 flanked by a SpeI restriction site and a Gly-Gly linker at the 5'-end and a Gly-456
Gly and a XhoI restriction site at the 3'-end by PCR and inserted into the linkers by restriction 457 digestion and ligation. Single site mutations (C478A/S482A (CASA) in nsP2 and D10A or V33E 458 in nsP3) were introduced into the replicon variants by insertion of custom-made DNA gBlocks 459 (IDT). These were integrated by restriction digestion with NdeI for nsP2 or ClaI (5'-end) and 460
BstAPI (3'-end) for nsP3 and ligation. 461 462 GST-ARTD10cat constructs were described previously [14] . pDest17-ARTD10cat constructs 463 were created from pDONRZeo-ARTD10cat [14] using the gateway cloning system. The cDNAs 464 encoding the catalytic domains of ARTD7 (N459-A656), ARTD8 (K1600-K1800), ARTD12 (G480-465 S688) and ARTD15 (N459-A656) were generated from plasmids obtained from H. Schüler 466 (Stockholm) and cloned into pDest17 using gateway cloning (Thermo Fisher Scientific). 467 pGEX4T1-ARTD12cat (489-684) was created from pNIC-28-BsaI-ARTD12 (M1-Q701) plasmid 468 that was obtained from O. Gileadi (Oxford) by gateway cloning. pDest17-nsP3, pDest17-nsP3-469 macro and pGEX4T1-NEMO were described previously [6, 58] . pDest17-nsP2 and pDest17-470 nsP2-459-798 were generated with the gateway cloning strategy using the SP6-CHIKV-471
replicon-SG-GLuc as a template. 472
473
The artificial protease substrate (pGEX4T1-nsP3/nsP4-site-polylinker-EGFP) was created 474 based on the long nsP3/nsP4 site described in Rausalu et al. [51] . This sequence was ordered 475 as oligos containing EcoRI (5'-end) and BamHI (3'-end) restriction sites mimicking overhangs 476 (5'-aattcGACGAGTTAAGACTAGACAGGGCAGGTGGGTATATATTCTCGTCGgag-3', 3'-477 gatcctcCGACGAGAATATATACCCACCTGCCCTGTCTAGTCTTAACTCGTCg-5') that were annealed 478 in vitro. The sequence encoding EGFP was isolated from pEGFP-N1 using BamHI and NotI 479 restriction sites and EGFP as well as the annealed oligos were inserted into pGEX4T1 using 480
EcoRI and BamHI restriction sites and ligation. Subsequently a polylinker was introduced into 481 this construct for better accessibility of the protease substrate. Therefore, oligos containing 482 this polylinker, the nsP3/nsP4 site and EcoRI (5'-end) and NcoI (3'-end) restriction site 483 GTCAAGGAACGCAAGTGACAGTATCCAGCTCCGGACTCAGATCTCGAG-3'). This sequence was 500 inserted into GW-pEGFP-nsP3-macro or GW-pEGFP-nsP3-macro-V33E using the AgeI and XhoI 501 restriction sites and ligation, replacing the EGFP. 502 503 pEVRFO-HA and the pEGFP-ARTD10 constructs were described previously [14, 59] . pHA-, 504 pEGFP-C1-and pcDNA5/FRT/TO-C-TAP-ARTD12 were created from the pNIC-28-BsaI-ARTD12 505 (M1-Q701) plasmid that was obtained from O. Gileadi (Oxford) by gateway cloning. Constructs 506 for expression of eukaryotic fusion proteins of nsP2, nsP2-459-798, nsP3 and nsP3-macro 507 were cloned into pcDNA3-Flag, pHA, pEGFP-C1 or pcDNA5/FRT/TO-N-TAP with gateway 508 cloning using the SP6-CHIKV-replicon-SG-GLuc as a template. Mutants (except for replicon 509 mutants, see above) were generated using standard mutagenesis procedures (e.g. Q5 510 mutagenesis kit (NEB)) and confirmed by sequencing. pcDNA3-HA-ARTD1 was a kind gift from 511 M. Hottiger (Zürich) and pCMV-HA-ARTD14 from Andreas Ladurner (München). 512 513
In vitro transcription of replicon RNA 514
For in vitro transcription of replicon RNA, DNA plasmids encoding the respective replicon 515 variants were first linearized with NdeI. Subsequently, linearized DNA was transcribed using 516 the mMESSAGE mMACHINE™ SP6 Transcription Kit (Thermo Fisher Scientific) according to the 517 manufacturer's instructions. Cap-analog [m 7 G(5')ppp(5')G] and GTP were added to the 518 reactions to obtain 5'-capped RNA. Afterwards template DNA was digested by addition of 519 TURBO DNase and RNA was precipitated using the lithium chloride precipitation protocol. 520
Finally, RNA was resuspended in elution buffer from the High Pure RNA isolation Kit (Roche). 521
Purity was controlled by agarose gel electrophoresis, concentration was measured using a 522 NanoDrop™ 1000 (Thermo Fisher Scientific) and RNA was stored at -80°C until transfection. 523 524
Purification of His6-and GST-tagged fusion proteins 525
His6-and GST-tagged fusion proteins were expressed in E. coli BL-21. The recombinant 526 proteins were enriched and purified via affinity chromatography on either glutathione-527 sepharose for GST-fusion or TALON metal affinity resin for His6-fusion proteins according to 528 standard protocols. Purification of His-nsP2-459-798, wt or inactive CASA mutant, took place 529 without the addition of PIC to the lysis buffer. 530 531
Replicon assays 532
In vitro transcribed replicon RNA was transfected into cells as described above (see 'In vitro 533 transcription of replicon RNA and Cell lines and cell culture'). 100 µl of supernatants were 534 collected 6, 9, 12, 24 and/or 30 hpt for analysis of Gaussia luciferase activity. Cells that were 535 not transfected with replicon RNA functioned as negative control. Gaussia luciferase is under 536 the control of the subgenomic promoter replacing the structural proteins and secreted into 537 the supernatant [46] . Determining the Gaussia luciferase in the supernatant can thus function 538 as a surrogate for CHIKV replication. To analyze the luciferase activity, the BioLux® Gaussia 539
Luciferase Assay Kit (NEB, discontinued) or the GAR-2B Gaussia Luciferase Assay (Targeting 540 Systems) were used according to the manufacturer's instructions following the "Stabilized 541 Assay Protocol I". In short, 5 ml of dilution buffer were mixed with 800 µl of stabilizer and 50 542 µl of 100x substrate and incubated protected from light for 25 min at room temperature. To determine ISGs among the mono-ARTDs, HeLa cells were stimulated with IFNa (180 U/mL). 552
Total RNA was isolated using the High Pure RNA isolation Kit (Roche) according to the 553 manufacturer's protocol. Reverse transcription was performed with 1 µg of the isolated RNA 554 using the QuantiTect Reverse Transcription Kit (Qiagen). mRNA expression levels of ARTD3, 555 ARTD7, ARTD12, ARTD14 and ARTD15 were analyzed by quantitative real-time PCR (qRT-PCR) 556
using QuantiTect Primer Assays (QIAGEN). In all settings the mRNA expression of the gene of 557 interest was normalized to GUS (forward 5'-CTCATTTGGAATTTTGCCGATT-3' and reverse 5'-558 CCGAGTGAAGATCCCCTTTTTA-3'; IDT). 559
560
In vitro ADP-ribosylation assays 561 ADP-ribosylation assays were performed in 30 µl reaction buffer (50 mM Tris, pH 8.0, 2 mM 562 TCEP, 4 mM MgCl2) with 50 µM b-NAD + and 1 µCi 32 P-NAD + . After 30 min incubation at 30°C 563 the reactions were stopped by addition of SDS sample buffer. Samples were fractionated by 564 SDS-PAGE and gels subsequently stained with Coomassie blue to visualize the proteins. For 565 the detection of the incorporated radioactive label, dried gels were exposed to X-ray films. 566 567 568 569
In vitro ADP-ribosylation assays with immunoprecipitated ARTD10 and ARTD12 570 HEK293 cells were seeded and after 48 h transfected with plasmids encoding HA-ARTD10 or 571 the inactive GW mutant or with plasmids encoding GFP-ARTD12 using the calcium phosphate 572 precipitation technique. 48 hpt cells were lysed in TAP lysis buffer (50 mM Tris, pH 7.5; 150 573 mM NaCl; 1 mM EDTA; 10% glycerol; 1% NP-40; 2 mM TCEP; PIC) and the lysates were 574 centrifuged at 4°C for 30 min. HA-ARTD10 was immunoprecipitated with 1 μl of anti-HA 575 (BioLegend) antibody and protein G beads and GFP-ARTD12 with 5 µl of GFP-Trap magnetic 576 agarose beads (Chromotek) at 4 °C for 1 h. Afterwards the beads were washed in TAP lysis 577 buffer and reaction buffer (50 mM Tris, pH 8.0, 2 mM TCEP, 4 mM MgCl2). ADP-ribosylation 578 assays were carried out as described above (chapter In vitro ADP-ribosylation assays). 579
580
In vitro protease assay 581
Bacterially expressed and purified His-nsP2-459-798, wt or inactive CASA mutant, were 582 incubated with synthetic substrate in 15 µl of reaction buffer (50 mM Tris, pH 8.0, 2 mM TCEP, 583 4 mM MgCl2) for 30, 60 or 120 min at 30°C. As a negative control substrate as well as proteases 584 were incubated alone in reaction buffer for 0 or 120 min at 30°C. The reactions were stopped 585 by the addition of SDS sample buffer. Samples were fractionated by SDS-PAGE and gels 586 subsequently stained with Coomassie blue to visualize the proteins. 587 588 ADP-ribosylation assay with subsequent in vitro protease assay 589 ADP-ribosylation assays were performed in 30 µl reaction buffer (50 mM Tris, pH 8.0, 2 mM 590 TCEP, 4 mM MgCl2) with 50 µM b-NAD + for 30 min at 30°C. Subsequently synthetic substrate 591 was added to the reactions and they were further incubated at 30°C for 30, 60 or 120 min at 592 30°C. As a negative control substrate was incubated alone in reaction buffer for 0 or 120 min 593 at 30°C. The reactions were stopped by the addition of SDS sample buffer. Samples were 594 fractionated by SDS-PAGE and gels subsequently stained with Coomassie blue or subjected to 595 immunoblotting to visualize the proteins. 596 597 Immunoprecipitation for detection of MARylation in cells 598 HEK293 cells were seeded in 10 cm plates and 48 h after seeding transfected with plasmid 599 DNA coding for GFP-nsP2 using the calcium phosphate precipitation technique or not treated. 600 24 h after DNA transfection or 72 h after seeding cells were transfected with in vitro 601 transcribed replicon RNA as described above (chapter Cell lines and cell culture) but scaled 602 up 10x according to the amount of medium. 30 hpt cells were harvested in RIPA buffer (10 mM 603
Tris, pH 7.4; 150 mM NaCl; 1% NP-40; 1% DOC; 0.1% SDS; PIC) and the lysates were centrifuged 604 at 4°C for 30 min. GFP-nsP2 or nsP2-2 EGFP translated from the replicon RNA were 605 immunoprecipitated with 5 µl GFP-Trap magnetic agarose beads (Chromotek) at 4°C for 1 h. 606
Afterwards beads were washed in RIPA buffer and reaction buffer (50 mM Tris, pH 8.0, 2 mM 607 TCEP, 4 mM MgCl2). Subsequent hydrolase assays were carried out with bacterially expressed 608 and purified His-nsP3-macro in 10 µl reaction buffer for 30 min at 30°C. The reactions were 609 stopped by the addition of SDS sample buffer. Samples were fractionated by SDS-PAGE and 610 subjected to immunoblotting to visualize MARylation using the MAR reagent (Millipore) and 611 the total proteins. 612 ARTD10+ARTD12 P = 0.0022; control vs. ARTD10-GW P = 0.0152; ARTD12 vs. ARTD12-HY P = 925 0.0152; ARTD12 vs. ARTD10+ARTD12 P = 0.0022; ARTD10 vs. ARTD10+ARTD12 P = 0.3095; 926 ARTD10 vs. ARTD10-GW P = 0.0022; (right panel) control vs. ARTD12 P = 0.0022; control vs. 927 ARTD12-HY P = 0.1320; control vs. ARTD10 P = 0.0022; control vs. ARTD10+ARTD12 P = 0.0022; 928 control vs. ARTD10-GW P = 0.0022; ARTD12 vs. ARTD12-HY P = 0.0022; ARTD12 vs. 929 ARTD10+ARTD12 P = 0.0022; ARTD10 vs. ARTD10+ARTD12 P = 0.0022; ARTD10 vs. GW P = 
